Correlation Between Cardio Diagnostics and Connect Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cardio Diagnostics and Connect Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cardio Diagnostics and Connect Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cardio Diagnostics Holdings and Connect Biopharma Holdings, you can compare the effects of market volatilities on Cardio Diagnostics and Connect Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cardio Diagnostics with a short position of Connect Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cardio Diagnostics and Connect Biopharma.

Diversification Opportunities for Cardio Diagnostics and Connect Biopharma

-0.28
  Correlation Coefficient

Very good diversification

The 3 months correlation between Cardio and Connect is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Cardio Diagnostics Holdings and Connect Biopharma Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Connect Biopharma and Cardio Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cardio Diagnostics Holdings are associated (or correlated) with Connect Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Connect Biopharma has no effect on the direction of Cardio Diagnostics i.e., Cardio Diagnostics and Connect Biopharma go up and down completely randomly.

Pair Corralation between Cardio Diagnostics and Connect Biopharma

Given the investment horizon of 90 days Cardio Diagnostics Holdings is expected to generate 1.99 times more return on investment than Connect Biopharma. However, Cardio Diagnostics is 1.99 times more volatile than Connect Biopharma Holdings. It trades about 0.03 of its potential returns per unit of risk. Connect Biopharma Holdings is currently generating about 0.04 per unit of risk. If you would invest  130.00  in Cardio Diagnostics Holdings on September 5, 2024 and sell it today you would lose (100.00) from holding Cardio Diagnostics Holdings or give up 76.92% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Cardio Diagnostics Holdings  vs.  Connect Biopharma Holdings

 Performance 
       Timeline  
Cardio Diagnostics 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Cardio Diagnostics Holdings are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very weak forward indicators, Cardio Diagnostics displayed solid returns over the last few months and may actually be approaching a breakup point.
Connect Biopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Connect Biopharma Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Connect Biopharma is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Cardio Diagnostics and Connect Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cardio Diagnostics and Connect Biopharma

The main advantage of trading using opposite Cardio Diagnostics and Connect Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cardio Diagnostics position performs unexpectedly, Connect Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Connect Biopharma will offset losses from the drop in Connect Biopharma's long position.
The idea behind Cardio Diagnostics Holdings and Connect Biopharma Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Other Complementary Tools

Bonds Directory
Find actively traded corporate debentures issued by US companies
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets